glp 1 glucagon dual receptor agonist PDB-101: Molecule of the Month: GLP-1 Agonists Science Behind GLP 1 GIP
Description
Han Y, Yue Y, Zhang K, Shen X
doi: 10.3389/fimmu.2016.00154 92 FriedrichMDiegelmannJSchauberJAuernhammerCJBrandS
Darren K
In fact, the inspiration for this article comes from both seeing remarkable anecdotal accounts from people on these drugs, but also the recent trials of Tirzepatide and Taltz showing actual benefit
It offers broader metabolic effects
In the absence of head-to-head comparisons, indirect evidence across heterogeneous trial populations with placebo or inferior active comparators provides limited guidance for clinical decision-making
